Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Treatment of Breast Implants With a Solution of Gentamicin, Vancomycin and Cefazolin Antibiotics for Women Undergoing Breast Reconstructive Surgery: a Randomized Controlled Trial (The BREAST-AB Trial)

NCT04731025 is registered in ClinicalTrials.gov with Mikkel Herly as lead sponsor.

NCT NCT04731025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04731025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Treatment of Breast Implants With a Solution of Gentamicin, Vancomycin and Cefazolin Antibiotics for Women Undergoing Breast Reconstructive Surgery: a Randomized Controlled Trial (The BREAST-AB Trial)
Lead sponsor
Mikkel Herly
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 27, 2021
Completion date
September 30, 2027
Enrollment
1,003 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic side effect, implant capsular contracture, implant complication, implant expulsion, implant infection, implant site infection, implant site pocket infection